Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease

被引：2
|
作者：
Ilona Joniec-Maciejak
Adriana Wawer
Danuta Turzyńska
Alicja Sobolewska
Piotr Maciejak
Janusz Szyndler
Dagmara Mirowska-Guzel
Adam Płaźnik
机构：
[1] Medical University of Warsaw,Department of Experimental and Clinical Pharmacology
[2] Centre for Preclinical Research and Technology (CePT),Department of Neurochemistry
[3] Institute of Psychiatry and Neurology,undefined
来源：
Pharmacological Reports | 2018年 / 70卷
关键词：
Parkinson’s disease; Octanoic acid; MPTP; PGC-1α; PEPCK;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：988 / 992
页数：4
相关论文
共 50 条
  • [1] Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease
    Joniec-Maciejak, Ilona
    Wawer, Adriana
    Turzynska, Danuta
    Sobolewska, Alicja
    Maciejak, Piotr
    Szyndler, Janusz
    Mirowska-Guzel, Dagmara
    Plaznik, Adam
    PHARMACOLOGICAL REPORTS, 2018, 70 (05) : 988 - 992
  • [2] Glatiramir acetate (Copaxone) causes restoration of the striatal dopamine in a progressive MPTP mouse model of Parkinson's disease
    Meshul, C. K.
    Churchill, M. J.
    MOVEMENT DISORDERS, 2016, 31 : S245 - S246
  • [3] Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson’s Disease
    M. Castro-Caldas
    A. Neves Carvalho
    E. Rodrigues
    C. J. Henderson
    C. R. Wolf
    C. M. P. Rodrigues
    M. J. Gama
    Molecular Neurobiology, 2012, 46 : 475 - 486
  • [4] Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson's Disease
    Castro-Caldas, M.
    Carvalho, A. Neves
    Rodrigues, E.
    Henderson, C. J.
    Wolf, C. R.
    Rodrigues, C. M. P.
    Gama, M. J.
    MOLECULAR NEUROBIOLOGY, 2012, 46 (02) : 475 - 486
  • [5] Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson's Disease
    Ardah, Mustafa T.
    Bharathan, Greeshma
    Kitada, Tohru
    Haque, M. Emdadul
    BIOMOLECULES, 2020, 10 (11) : 1 - 17
  • [6] The striatal level of PEP-19 is reduced in the MPTP mouse model of Parkinson's disease
    Svensson, M.
    Skold, K.
    Nilsson, A.
    Caprioli, R.
    Svenningsson, P.
    Andren, P.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S193 - S193
  • [7] Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease
    Zhao, Xin
    Li, Quan
    Zhao, Lei
    Pu, XiaoPing
    PROTEOMICS CLINICAL APPLICATIONS, 2007, 1 (12) : 1559 - 1569
  • [8] PYM50028 restores dopamine transporter (DAT) levels in striatal dopamine terminals in a MPTP-lesioned mouse model of Parkinson's disease
    Visanji, N. P.
    Johnston, T. H.
    Brotchie, J. M.
    Hatton, S. L.
    Callizot, N.
    Orsi, A.
    Rees, D.
    MOVEMENT DISORDERS, 2006, 21 : S643 - S643
  • [9] Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson’s disease
    Rainer K. W. Schwarting
    Marco Sedelis
    Katja Hofele
    Georg W. Auburger
    Joseph P. Huston
    Neurotoxicity Research, 1999, 1 : 41 - 56
  • [10] Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease
    Schwarting, Rainer K. W.
    Sedelis, Marco
    Hofele, Katja
    Auburger, Georg W.
    Huston, Joseph P.
    NEUROTOXICITY RESEARCH, 1999, 1 (01) : 41 - 56
12345